BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Tuesday, April 23, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
March 24, 2015
View Archived Issues
Genmab buys anti-DR5 antibodies and IP from iDD Biotech
Read More
Selexipag shows efficacy for the treatment of PAH
Read More
Stevia and BioViva collaborate on genetic therapies for diabetes and obesity
Read More
Vect-Horus discloses neurotensin analogue for therapeutic hypothermia induction
Read More
Janssen patents mGluR2 positive allosteric modulators
Read More
Bristol-Myers Squibb describes RORgamma modulators
Read More
Biogen: new identity for Biogen Idec
Read More
Artery Therapeutics presents data on ABCA1 agonist peptide CS-6253
Read More
EAU Madrid: Long-term results from the everolimus EXIST-2 trial
Read More
High clinical efficacy of ranpirnase demonstrated against HPV infection
Read More
Masitinib receives FDA orphan drug designation for amyotrophic lateral sclerosis
Read More
Gilead Sciences begins phase I study of GS-5829
Read More
Celdara Medical begins phase I trial of chimeric-antigen receptor T cells
Read More
Stempeucel receives EMA advanced therapy medicinal product classification
Read More
Prozymex patents DPP-I inhibitors
Read More
Hayashikane Sangyo develops blood-vessel improving agents
Read More
Scancell's SCIB-2 DNA vaccine synergizes with immune checkpoint inhibitors against tumor cells
Read More
Orphan Technologies enzyme replacement therapy receives U.S. orphan designation for homocystinuria
Read More
University of Copenhagen's placental malaria vaccine ready for phase I studies
Read More
World Tuberculosis Day: a reminder about the ongoing epidemic
Read More
Medigene initiates first company-sponsored study of DC vaccine for AML
Read More
Takeda licenses rights to ImmunoGen's antibody-drug conjugate technology
Read More
Cerulean's phase Ib/II trial of CRLX-101 and bevacizumab in RCC meets primary endpoint
Read More
Vertex reports on phase II trial of VX-661 and ivacaftor in F508del-homozygous CF
Read More
First proof-of-concept for 64Cu-DOTA-AE-105 in bladder cancer
Read More